MPWR stock · PCRX stock

MPWR vs PCRX · P/E 112, rev $1.78B vs P/E 174, rev $369.8M

Monolithic Power Systems Inc (MPWR) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.

Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.

Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Latest reported MPWR revenue for 2026-06-30 was $1.78B. Net income was $450.5M. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.

Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.

MPWR currently screens at market cap $77.49B and trailing P/E 112.3. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.

Not investment advice. Open the MPWR and PCRX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons